💡Information


The publicly listed company Liminatus Pharma plans to establish a subsidiary named "American BNB Strategy" and aims to raise and deploy up to $500 million in phases, with the goal of making strategic long-term investments in #BNB# . Despite fully committing to its core business, Liminatus believes that expanding into the digital asset space is critical to supporting long-term growth and enhancing shareholder value.
BNB-4.18%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)